“SLC39A1 Contributes to Gemcitabine Resistance of Pancreatic Ductal Adenocarcinoma by Activating AMPK Signaling”. Bangladesh Journal of Pharmacology, vol. 19, no. 2, June 2024, pp. 52-58, https://doi.org/10.3329/bjp.v19i2.72787.